As many of the mutations linked to AD, such as those in the APP, PSEN1, and PSEN2 genes, often involve specific point mutations that could potentially be corrected at the DNA level using base editing (Sasaguri et al., 2018; Naeem et al., 2020). This evidence concerns the gene APP and Alzheimer disease.